Dietary emulsifier consumption accelerates type 1 diabetes development in NOD mice

Area of Science:

• Immunology
• Microbiome research
• Nutritional science

Background:

• Type 1 diabetes (T1D) prevalence is rising, suggesting environmental factors play a key role.
• Industrialized diets and their impact on gut microbiota are implicated in T1D development.
• Dietary emulsifiers disrupt gut microbiota, potentially leading to inflammation and metabolic dysfunction.

Purpose of the Study:

• To investigate the effects of two common dietary emulsifiers, carboxymethylcellulose (CMC) and polysorbate-80 (P80), on T1D development.
• To assess the impact of emulsifiers on gut microbiota composition and function, and intestinal inflammation in a T1D mouse model.

Main Methods:

• NOD mice, a model for spontaneous T1D, were chronically exposed to CMC and P80.
• Changes in T1D incidence, insulin autoantibody levels, gut microbiota composition/function, and intestinal inflammation were monitored.
• Machine learning was used to analyze the relationship between microbiota disruption and disease development.

Main Results:

• Chronic exposure to CMC and P80 accelerated T1D development in NOD mice.
• Emulsifier treatment increased insulin autoantibody levels and induced low-grade intestinal inflammation.
• Significant alterations in gut microbiota composition and function were observed, with disruption severity partially predicting disease onset.

Conclusions:

• Dietary emulsifiers like CMC and P80 can accelerate T1D development by disrupting gut microbiota homeostasis and promoting intestinal inflammation.
• These findings suggest that emulsifiers in industrialized diets may contribute to the increasing incidence of T1D.
• Complex interactions between host genetics, diet, and the gut microbiota are critical in T1D pathogenesis.